Quest PharmaTech Inc. (TSXV:QPT)
Canada · Delayed Price · Currency is CAD 0.0250
0.00 (0.00%)
At close: Sep 24, 2026
Quest PharmaTech Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.23M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2026 | - | - | - |
| Jan 31, 2025 | - | - | - |
| Jan 31, 2024 | - | - | - |
| Jan 31, 2023 | - | - | - |
| Jan 31, 2022 | - | - | - |
| Jan 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Innovotech | 3.72M |
| Glow Lifetech | 2.31M |
| Restart Life Sciences | 465.72K |
| ASEP Medical Holdings | 336.77K |
| Kane Biotech | 38.72K |
Quest PharmaTech News
- 4 months ago - Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis - GlobeNewsWire
- 1 year ago - Quest PharmaTech Announces Results from AGM - GlobeNewsWire
- 1 year ago - Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech - GlobeNewsWire